BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7948948)

  • 21. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function.
    Zhang W; McClain C; Gau JP; Guo XY; Deisseroth AB
    Cancer Res; 1994 Aug; 54(16):4448-53. PubMed ID: 8044794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disturbance of the normal cell cycle by T antigens of SV40 viruses and JC cause some tumors].
    Kryńska B; Lewin-Kowalik J; Sieroń AL
    Postepy Hig Med Dosw; 1998; 52(3):237-57. PubMed ID: 9789434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells.
    Abraham J; Spaner D; Benchimol S
    Oncogene; 1999 Feb; 18(8):1521-7. PubMed ID: 10102621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif.
    Addison C; Jenkins JR; Stürzbecher HW
    Oncogene; 1990 Mar; 5(3):423-6. PubMed ID: 2156209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of switching on p53: a role for covalent modification?
    Meek DW
    Oncogene; 1999 Dec; 18(53):7666-75. PubMed ID: 10618706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
    van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
    J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs.
    Hecker D; Page G; Lohrum M; Weiland S; Scheidtmann KH
    Oncogene; 1996 Mar; 12(5):953-61. PubMed ID: 8649812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation.
    Vaghefi H; Neet KE
    Oncogene; 2004 Oct; 23(49):8078-87. PubMed ID: 15361854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of LT-antigen/p53 complex by heat treatment correlates with inhibition of DNA synthesis during transforming infection with SV40.
    Khandjian EW; Rose TM
    Biochem Cell Biol; 2000; 78(4):437-45. PubMed ID: 11012082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of the C-terminal sites of human p53 reduces non-sequence-specific DNA binding as modeled with synthetic peptides.
    Hoffmann R; Craik DJ; Pierens G; Bolger RE; Otvos L
    Biochemistry; 1998 Sep; 37(39):13755-64. PubMed ID: 9753464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multisite protein modification and intramolecular signaling.
    Yang XJ
    Oncogene; 2005 Mar; 24(10):1653-62. PubMed ID: 15744326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of T antigen interactions with p53 in tumorigenesis.
    Pipas JM; Levine AJ
    Semin Cancer Biol; 2001 Feb; 11(1):23-30. PubMed ID: 11243896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
    Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
    Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding.
    Fuchs B; Hecker D; Scheidtmann KH
    Eur J Biochem; 1995 Mar; 228(3):625-39. PubMed ID: 7737156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifications of p53: competing for the lysines.
    Carter S; Vousden KH
    Curr Opin Genet Dev; 2009 Feb; 19(1):18-24. PubMed ID: 19179064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ dephosphorylation of p53 protein by calf intestinal alkaline phosphatase treatment.
    Baunoch DA; Xu M; Tewari A; Christman JK; Lane MA
    Oncogene; 1992 Nov; 7(11):2351-3. PubMed ID: 1437159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating protein-DNA interactions by post-translational modifications at disordered regions.
    Vuzman D; Hoffman Y; Levy Y
    Pac Symp Biocomput; 2012; ():188-99. PubMed ID: 22174274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-translational modifications and activation of p53 by genotoxic stresses.
    Appella E; Anderson CW
    Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SV40 Tag/p53 complexes actively promote malignant cell growth of human mesothelial cells.
    Bocchetta M; Carbone M
    Cell Oncol; 2008; 30(5):455. PubMed ID: 18853526
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of new p53 acetylation sites in COS-1 cells.
    Joubel A; Chalkley RJ; Medzihradszky KF; Hondermarck H; Burlingame AL
    Mol Cell Proteomics; 2009 Jun; 8(6):1167-73. PubMed ID: 19155208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.